Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
30m
Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022.
3m
Dr Reddy’s Hetero ties up with Gilead Sciences for anti-HIV drug Lenacapavir
Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Walz, Vance VP debate
Helene's wake
Teacher wins pronouns case
NASCAR sued by Jordan
MS-13 associate sentenced
Repairman's claims rejected
US warns foreign operators
'American Pickers' star dies
Suspended five games
Michel sues Hill for fraud
Files for bankruptcy
CA food chemicals ban
Sworn in as Mexico's pres
CA sues Catholic hospital
'Good Times' star dies
Drop box ban lawsuit
Sex offender registry ruling
120 new assault allegations
Israel sends more troops
Louisiana abortion pills law
Man sentenced for cloning
US new vehicle sales fall
3.5 quake rattles SoCal
CO2 found on Pluto's moon
Labor board targets Apple
Court reinstates Indiana suit
US job openings rebound
Historic ship reef plan
GA disaster declaration
DOJ report on GA prisons
Blasts near Israeli Embassy
Feedback